TrialDiabetes care2013

Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: a 1-year, randomized, double-blind, placebo-controlled study.

Janet B McGill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.